e-learning
resources
Amsterdam 2011
Sunday, 25.09.2011
Accelerated lung ageing in COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Therapeutic implications
P. J. Barnes (London, United Kingdom)
Source:
Annual Congress 2011 - Accelerated lung ageing in COPD
Session:
Accelerated lung ageing in COPD
Session type:
Symposium
Number:
1397
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. J. Barnes (London, United Kingdom). Therapeutic implications. Annual Congress 2011 - Accelerated lung ageing in COPD
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Therapeutic and management implications
Source: Annual Congress 2010 - Similarities and differences between asthma and COPD: the "Dutch Hypothesis" revisited
Year: 2010
Therapeutic implications
Source: Annual Congress 2009 - The lung cancer-COPD nexus
Year: 2009
Therapeutic implications
Source: Annual Congress 2011 - Why are small airways important in asthma? An ERS/World Allergy Organization joint symposium
Year: 2011
Clinical implications
Source: Annual Congress 2007 - Pulmonary biomarkers in COPD
Year: 2007
Clinical implications and novel therapies
Source: International Congress 2018 – Accelerated ageing in lungs
Year: 2018
Clinical implications and opportunities for new drug therapies
Source: Annual Congress 2008 - Deadly networks: disease-causing protein and DNA modifications
Year: 2008
Therapeutic management - Current status and future developments
Source: COVID-19 Videos
Year: 2020
Clinical implications – potential future developments in EBC research
Source: Annual Congress 2007 - ERS/ATS joint symposium: the report of the ERS/ATS Task Force on Exhaled Breath Condensate
Year: 2007
Oxygen at home: benefits, practical implications and pitfalls
Source: Annual Congress 2012 - Primary Care Programme
Year: 2012
Individualised staging: practical implications
Source: European Multidisciplinary Conference in Thoracic Oncology 2009
Year: 2009
Perspectives for the future
Source: Eur Respir Monogr 2016; 71: 260-274
Year: 2016
Therapeutic strategies: what treatment for what patient
Source: Annual Congress 2008 - PG12 - Challenges in pulmonary embolism: hot issues and interactive cases (jointly organised with ACCP)
Year: 2008
Indications and Rationale
Source: School Course 2012 - Practical Issues in Pulmonary Rehabilitation
Year: 2012
Targeting mucus as a new therapeutic avenue?
Source: Annual Congress 2011 - Mucus in airway diseases: bad or good partner?
Year: 2011
Physiologic rationale and clinical pitfalls
Source: Virtual Congress 2021 – High flow nasal cannula in adults with acute respiratory failure
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept